Skip to content

High Frequency RF Current Effects on Muscle Pain and Function

RecruitingNot applicableNCT05345015
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study is to examine the acute and chronic effects of high frequency electrical current transfer (frequently called "TECAR") on pain and functional movement in individuals with a musculoskeletal injury or pain. The participants will be assigned into an experimental or a control group and outcome measures will be measured prior to, after, 24 and 48 hours following a single intervention session (Acute effects) as well as 3 and 6 months after the intervention (chronic effects).

Study details

Official title
Acute and Chronic Effects of High Frequency RF Electrical Current on Pain and Muscle Function in Individuals With Musculoskeletal Pain
Conditions
Interventions
  • Device: Radiofrequency Energy Transfer
  • Device: Transcutaneous Nerve Stimulation
Sponsor
Aristotle University Of Thessaloniki
Start date
2022-09-01
Primary completion
2028-05-31
Sex
All
Age range
from 18 Years to 65 Years
Results posted
No results posted in this snapshot
Countries
Greece
Total sites listed
2

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Individuals with Muscle Injury Inclusion Criteria: * Age over 18 years. * Athletes: amateur soccer players or sprinters with regular, systematic training. * Suspected Grade I or II hamstring strain. * Cessation of training due to injury. * No surgical intervention in the previous year (for initial assessment as potential participants). Exclusion Criteria: * History of injury to the same muscle (ipsilateral side) within the last 6 months. * Other injury to the posterior aspect of the thigh. * Other injuries or chronic pain in the trunk or lower limbs. * Use of non-steroidal anti-inflammatory drugs (NSAIDs) in the 3 months prior to the injury. Individuals with Acute Low Back Pain Inclusion Criteria: * Age over 18 years. * Pain located between the lower ribs and the gluteal folds (top of the buttocks). * Pain occurred on fewer than half of the days over the preceding six months. * Pain intensity $\\ge$ 6/10 on the Visual Analogue Scale (VAS). * Pain related to one or more of the following: * Lumbar facet joints * Sacroiliac joints * Lumbar intervertebral discs * Muscles, tendons, or ligaments of the lumbar and sacral region * Other bony structures of the lumbar spine * Discontinuation of non-steroidal anti-inflammatory drugs (NSAIDs) or analgesics: * 1 day prior to measurement * 48 hours after measurement Exclusion Criteria: * Radiographic evidence of inflammatory disease affecting the spine. * Spinal fracture. * Significant genetic structural abnormality of the spine. * Pregnancy. * Psychiatric disorders. * Receipt of systemic medication or treatment in the last 3 months. * Presence of neurological deficits (sensory, motor, or reflexes). * Receipt of TENS or TECAR therapy within the last year. Individuals with Chronic Low Back Pain Inclusion Criteria: * Episodes of low back pain (between the lower rib margin and the gluteal fold) for at least half of the days during the last 6 months. * Pain intensity $\\ge$ 20% on the Visual Analogue Scale (VAS). Exclusion Criteria: * Spinal stenosis. * Radiographic evidence of inflammatory disease affecting the spine. * Vertebral fracture. * Presence of spondylolisthesis or spondylolytic lesion (spondylolysis). * Significant genetic structural abnormality of the spine. * Daily, severe low back pain. * Pregnancy. * Use of medications that might influence heart rate or blood pressure. * Psychiatric disorders.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05345015